Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,774.50
-3.50 (-0.20%)
24 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Gsk Plc LSE:GSK London Stock Exchange Ordinary Share GB00BN7SWP63 ORD 31 1/4P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   -3.50 -0.20 1,774.50 1,774.00 1,774.50 1,793.50 1,766.50 1780 4,163,088 15:29:10   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.82 73.06B
 Type  Size  Price  Time  Units 
  485 1,774.50 15:50:16 GBX
 
Recent News
DateTimeSource
HeadlineMore GSK News
24/05/202408:36ALNCTOP NEWS: GSK celebrates Illinois jury verdict in Valadez case
24/05/202408:36ALNCTOP NEWS: GSK celebrates Illinois jury verdict in Valadez case
24/05/202407:00LSEG_RNSGSK PLC Statement: Zantac (ranitidine) litigation
21/05/202408:49ALNCGSK's depemokimab asthma treatment meets endpoints in latest trials
21/05/202408:49ALNCGSK's depemokimab asthma treatment meets endpoints in latest trials
21/05/202407:00LSEG_RNSGSK PLC Positive phase III asthma results for depemokimab
20/05/202416:11ALNCIN BRIEF: GSK executive buys GBP20,026 worth shares
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
24/05/202408:19PBBGlaxosmithkline - The recovery32,978
01/02/202410:22PBBGlazoSmithKline - News & Information143
24/09/202321:42PBBGLAXOSMITHKLINE WITH CHARTS & NEWS189
17/04/202319:25PBBGsk zantac2
28/02/202316:35PBBGSK launched Shingrix, which has a far superior shingles prevention effect1
01/09/202215:17PBBGSK - just mucking around4
23/01/202114:27PBBIn Rude Health!2
06/10/202016:28PBBcovid vaccines not needed.. Trump. Calls experimental drugs "miracles from god"3
31/03/202007:46PBBCOVID-19..downgraded no longer high consequence infectious disease1
13/03/202016:09PBBgovt virus chief worked for Glaxo..vested interest with vaccine..ha,ha!2
Newsletter articles for Gsk Plc
DateTimeNewsletterHeadline
28/7/202214:55Tom Winnifrith's N50GSK – half-year update, what now after consumer health business demerger?
28/4/202208:21Tom Winnifrith's N50GlaxoSmithKline – Q1 update, further share price upside as demerger nears
01/3/202210:13Building an income portfolio with Clem ChambersIncome Investors Need To Be More Aggressive Now
24/2/202207:07Tom Winnifrith's N50GlaxoSmithKline – Consumer Healthcare business named and demerger “on track”, still not too late to Buy
11/2/202211:43Tom Winnifrith's N50GlaxoSmithKline – 2021 results, “strong commercial execution”?
29/7/202116:40Tom Winnifrith's N50GlaxoSmithKline – second quarter results, still a recovery buy
02/7/202113:53Tom Winnifrith's N50GlaxoSmithKline – a Recovery Buy
More newsletter articles
Data Downloads for GSK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Gsk Plc
Get quick technical analysis for Gsk Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Gsk Plc Articles